Claire Kelly Source Confirmed

OverviewAI-generated summary

Claire Kelly's research investigates metabolic changes in glioblastomas, particularly in response to choline kinase inhibition. Her work has utilized in vivo magnetic resonance spectroscopy (MRS) and clustered dynamic contrast-enhanced MRI parameters in rodent models to assess tumor haemodynamic heterogeneity and response to treatment. Kelly has also explored the hypoxia-dependent inhibition of glioblastoma cell proliferation, invasion, and metabolism by the choline-kinase inhibitor JAS239. In addition to her work in cancer research, Kelly has contributed to studies on veterinary education, examining how service-learning experiences can foster competence in veterinary students within the Competency-Based Veterinary Education Model. Her other research interests include steatotic liver disease and its association with frailty, the prevalence of depression among liver transplant patients, and radiological-histological discordance in patients transplanted for hepatocellular carcinoma (HCC). Kelly holds an h-index of 9 with 42 publications and 586 citations.

Metrics

• h-index: 9
• Publications: 42
• Citations: 586